145 related articles for article (PubMed ID: 38924104)
21. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.
Avnet S; Lemma S; Cortini M; Pellegrini P; Perut F; Zini N; Kusuzaki K; Chano T; Grisendi G; Dominici M; De Milito A; Baldini N
Oncotarget; 2016 Sep; 7(39):63408-63423. PubMed ID: 27566564
[TBL] [Abstract][Full Text] [Related]
22. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
[TBL] [Abstract][Full Text] [Related]
23. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
Tsai HC; Huang CY; Su HL; Tang CH
PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
[TBL] [Abstract][Full Text] [Related]
24. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
25. LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy.
Long XH; Zhong ZH; Peng AF; Zhu LB; Wang H; Zhang GM; Liu ZL
Mol Med Rep; 2014 Dec; 10(6):2967-72. PubMed ID: 25310590
[TBL] [Abstract][Full Text] [Related]
26. Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3/SLC7A11 pathway.
Nie J; Ling Y; Jin M; Chen Z; Liu W; Shen W; Fang T; Li J; He Y
Eur J Pharmacol; 2023 Oct; 957():176009. PubMed ID: 37619784
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
28. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Lin Z; Xie X; Lu S; Liu T
Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
[TBL] [Abstract][Full Text] [Related]
29. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
Chen M; Jiang Y; Sun Y
Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
[TBL] [Abstract][Full Text] [Related]
30. Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells.
Chen W; Li Z; Yu N; Zhang L; Li H; Chen Y; Gong F; Lin W; He X; Wang S; Wu Y; Ji G
J Nanobiotechnology; 2023 Sep; 21(1):355. PubMed ID: 37775799
[TBL] [Abstract][Full Text] [Related]
31. Capsaicin Enhanced the Efficacy of Photodynamic Therapy Against Osteosarcoma via a Pro-Death Strategy by Inducing Ferroptosis and Alleviating Hypoxia.
Wang Y; Zhou X; Yao L; Hu Q; Liu H; Zhao G; Wang K; Zeng J; Sun M; Lv C
Small; 2024 Jun; 20(26):e2306916. PubMed ID: 38221813
[TBL] [Abstract][Full Text] [Related]
32. Advances in emerging drugs for osteosarcoma.
Hattinger CM; Fanelli M; Tavanti E; Vella S; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2015 Sep; 20(3):495-514. PubMed ID: 26021401
[TBL] [Abstract][Full Text] [Related]
33. Ferroptosis in osteosarcoma: A promising future.
Liu X; Du S; Wang S; Ye K
Front Oncol; 2022; 12():1031779. PubMed ID: 36457488
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
35. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
[TBL] [Abstract][Full Text] [Related]
36. Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway.
Zhu Y; Yang L; Yu Y; Xiong Y; Xiao P; Fu X; Luo X
Oncol Res; 2024; 32(5):899-910. PubMed ID: 38686047
[TBL] [Abstract][Full Text] [Related]
37. Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma.
He C; Jiang Y; Guo Y; Wu Z
Small; 2023 Nov; 19(44):e2302575. PubMed ID: 37394717
[TBL] [Abstract][Full Text] [Related]
38. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
[TBL] [Abstract][Full Text] [Related]
39. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy.
Jamali Z; Taheri-Anganeh M; Shabaninejad Z; Keshavarzi A; Taghizadeh H; Razavi ZS; Mottaghi R; Abolhassan M; Movahedpour A; Mirzaei H
IUBMB Life; 2020 Jul; 72(7):1306-1321. PubMed ID: 32233112
[TBL] [Abstract][Full Text] [Related]
40. Advances in differentiation therapy for osteosarcoma.
Chen Y; Cao J; Zhang N; Yang B; He Q; Shao X; Ying M
Drug Discov Today; 2020 Mar; 25(3):497-504. PubMed ID: 31499188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
